Confirmed by Rick Shea on today’s webcast that MNTA interprets the “markers of activity” item in the FDA’s five criteria for generic Lovenox to mean assays for PK/PD, as noted in #msg-62667654.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”